Mr. Michel Sidibe, the African Special Envoy for the African Medicine Agency (AMA), held a virtual meeting with a section of African representatives to the Board and Committees of the Global Fund and the African Constituency Bureau (ACB) on the 3rd of March 2022. In the meeting were; Prof Pascal Niamba, the Board member for…
Details
The Global Fund 7th replenishment investment case was unveiled during the Global Fund preparatory meeting, that was hosted virtually by a coalition of five countries namely; the Democratic Republic of the Congo, Kenya, Rwanda, Senegal and South Africa on February 23, 2022. The Global Fund’s target for the Seventh Replenishment aims at raising at least…
Details
A new HIV variant, more virulent and contagious, has emerged. This variant, known as VB, causes an early onset of opportunistic diseases, however It could not spread owing to the effectiveness of prevention and ARV treatment programs implemented in the Netherlands where it is circulating. A new variant of the human immunodeficiency virus (HIV) that…
Details
The fight against HIV, TB and malaria is very often focused on an exclusively hygienic, therapeutic or biomedical approach. This paper does not question the interest or the relevance of such an approach, but it suggests that we should resolutely broaden the scope of this fight to the borders of social inequalities. Actually, health as…
Details
Following the case of Rwanda, one of the GF grants’ implementing countries, the Community Health Program was instituted in 1995 and started with just about 12,000 health workers and was initially conceived as a response to the major public health problems that had developed because of the previous year’s war and the 1994 Genocide against…
Details
The Sustainability, Transition and Co-financing policy follows the Global Fund’s principle of additionality – the GF adds to local resources to fight the three diseases, it does not replace them. It spells out the domestic funding requirements from government in countries where the GF invests. Some conditions apply to all countries where the GF invests.…
Details
Globally, new HIV infections declined by 44% between 2000 and 2021, missing the global target for a 75% reduction in new infections by 2020. The Global Fund Technical Evaluation Reference Group (TERG) published a thematic review on primary HIV prevention, in May 2021 to weigh in on discussions for the 2023-28 Global Fund Strategy. This…
Details
Health has long been a complicated and tragic topic in Africa. By April 2001, Southern African Development Community (SADC) governments together with other African Union member states, had met in Abuja, Nigeria, and signed the Abuja Declaration on health in Africa. It was a historic moment as Africa pledged a new commitment to eliminating the…
Details
The Global Fund’s new 2020-2023 grant implementation cycle has been launched with the expectation that it will produce greater results in the 23 countries of the West and Central African constituency. This builds on the fact that these countries have started to implement the recommendations of the Global Fund’s Office of the Inspector General, which…
Details
The two African constituencies are represented mostly in pairs at the Global Fund three committees (the Strategy, Ethics and Governance; and at the Audit and Finances committees) and at the Board by the committee, board and alternate members representing the West and Central Africa and the East and South Africa. Both regions combine 46 African…
Details